Annual SG&A
$10.95 B
-$299.00 M-2.66%
31 December 2023
Summary:
Abbott Laboratories annual selling, general & administrative expenses is currently $10.95 billion, with the most recent change of -$299.00 million (-2.66%) on 31 December 2023. During the last 3 years, it has risen by +$1.25 billion (+12.92%). ABT annual SG&A is now -3.31% below its all-time high of $11.32 billion, reached on 31 December 2021.ABT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.90 B
-$41.00 M-1.40%
30 September 2024
Summary:
Abbott Laboratories quarterly selling, general & administrative expenses is currently $2.90 billion, with the most recent change of -$41.00 million (-1.40%) on 30 September 2024. Over the past year, it has increased by +$172.00 million (+6.32%). ABT quarterly SG&A is now -31.70% below its all-time high of $4.24 billion, reached on 30 September 2011.ABT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$152.97 B
+$2.14 B+1.42%
30 September 2024
Summary:
Abbott Laboratories TTM selling, general & administrative expenses is currently $152.97 billion, with the most recent change of +$2.14 billion (+1.42%) on 30 September 2024. Over the past year, it has increased by +$141.78 billion (+1266.09%). ABT TTM SG&A is now at all-time high.ABT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -2.7% | +6.3% | +1266.1% |
3 y3 years | +12.9% | +4.6% | +1310.4% |
5 y5 years | +12.4% | +18.6% | +1475.3% |
ABT Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -3.3% | +12.9% | -5.0% | +6.3% | at high | +32.2% |
5 y | 5 years | -3.3% | +12.9% | -5.0% | +27.2% | at high | +53.5% |
alltime | all time | -3.3% | +1170.0% | -31.7% | +216.4% | at high | +9164.5% |
Abbott Laboratories Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.90 B(-1.4%) | $11.51 B(+1.5%) |
June 2024 | - | $2.94 B(-0.8%) | $11.34 B(+1.8%) |
Mar 2024 | - | $2.96 B(+8.6%) | $11.15 B(+1.8%) |
Dec 2023 | $10.95 B(-2.7%) | $2.72 B(+0.0%) | $10.95 B(-2.2%) |
Sept 2023 | - | $2.72 B(-0.6%) | $11.20 B(-0.1%) |
June 2023 | - | $2.74 B(-0.8%) | $11.21 B(-0.2%) |
Mar 2023 | - | $2.76 B(-7.1%) | $11.22 B(-0.2%) |
Dec 2022 | $11.25 B(-0.7%) | $2.97 B(+8.9%) | $11.25 B(-0.7%) |
Sept 2022 | - | $2.73 B(-0.9%) | $11.32 B(-0.3%) |
June 2022 | - | $2.76 B(-1.1%) | $11.36 B(+0.3%) |
Mar 2022 | - | $2.79 B(-8.6%) | $11.33 B(+0.0%) |
Dec 2021 | $11.32 B(+16.8%) | $3.05 B(+10.2%) | $11.32 B(+4.4%) |
Sept 2021 | - | $2.77 B(+1.5%) | $10.85 B(+4.5%) |
June 2021 | - | $2.73 B(-2.0%) | $10.38 B(+4.5%) |
Mar 2021 | - | $2.78 B(+8.3%) | $9.93 B(+2.4%) |
Dec 2020 | $9.70 B(-0.7%) | $2.57 B(+11.6%) | $9.70 B(+1.6%) |
Sept 2020 | - | $2.30 B(+1.1%) | $9.54 B(-1.4%) |
June 2020 | - | $2.28 B(-10.7%) | $9.68 B(-1.6%) |
Mar 2020 | - | $2.55 B(+5.6%) | $9.84 B(+0.7%) |
Dec 2019 | $9.77 B(+0.2%) | $2.41 B(-1.1%) | $9.77 B(+0.6%) |
Sept 2019 | - | $2.44 B(+0.2%) | $9.71 B(+0.7%) |
June 2019 | - | $2.43 B(-1.8%) | $9.65 B(-0.3%) |
Mar 2019 | - | $2.48 B(+5.0%) | $9.68 B(-0.7%) |
Dec 2018 | $9.74 B(+6.1%) | $2.36 B(-0.8%) | $9.74 B(-1.2%) |
Sept 2018 | - | $2.38 B(-3.6%) | $9.86 B(+2.7%) |
June 2018 | - | $2.47 B(-3.0%) | $9.60 B(+3.4%) |
Mar 2018 | - | $2.54 B(+2.6%) | $9.28 B(+1.1%) |
Dec 2017 | $9.18 B(+36.3%) | $2.48 B(+17.1%) | $9.18 B(+9.6%) |
Sept 2017 | - | $2.12 B(-1.6%) | $8.38 B(+6.2%) |
June 2017 | - | $2.15 B(-11.9%) | $7.89 B(+5.5%) |
Mar 2017 | - | $2.44 B(+45.8%) | $7.48 B(+11.0%) |
Dec 2016 | $6.74 B(-0.7%) | $1.67 B(+2.8%) | $6.74 B(+0.3%) |
Sept 2016 | - | $1.63 B(-6.3%) | $6.72 B(-0.6%) |
June 2016 | - | $1.74 B(+2.3%) | $6.76 B(+0.1%) |
Mar 2016 | - | $1.70 B(+2.6%) | $6.75 B(-0.6%) |
Dec 2015 | $6.79 B(+3.9%) | $1.66 B(-0.7%) | $6.79 B(-0.2%) |
Sept 2015 | - | $1.67 B(-3.5%) | $6.80 B(+1.1%) |
June 2015 | - | $1.73 B(-0.6%) | $6.72 B(+1.2%) |
Mar 2015 | - | $1.74 B(+4.3%) | $6.65 B(+1.8%) |
Dec 2014 | $6.53 B(+2.5%) | $1.67 B(+4.5%) | $6.53 B(+2.0%) |
Sept 2014 | - | $1.59 B(-3.3%) | $6.41 B(-0.3%) |
June 2014 | - | $1.65 B(+1.8%) | $6.42 B(-1.0%) |
Mar 2014 | - | $1.62 B(+5.1%) | $6.49 B(-2.5%) |
Dec 2013 | $6.37 B(-5.4%) | $1.54 B(-4.4%) | $6.65 B(+6.1%) |
Sept 2013 | - | $1.61 B(-6.0%) | $6.27 B(-4.7%) |
June 2013 | - | $1.71 B(-4.0%) | $6.58 B(-1.5%) |
Mar 2013 | - | $1.79 B(+54.2%) | $6.68 B(-0.8%) |
Dec 2012 | $6.74 B(-8.6%) | $1.16 B(-39.7%) | $6.73 B(+118.0%) |
Sept 2012 | - | $1.92 B(+5.9%) | $3.09 B(-42.9%) |
June 2012 | - | $1.81 B(-1.5%) | $5.41 B(-14.9%) |
Mar 2012 | - | $1.84 B(-174.1%) | $6.36 B(-13.7%) |
Dec 2011 | $7.37 B(-29.0%) | -$2.49 B(-158.7%) | $7.37 B(-41.8%) |
Sept 2011 | - | $4.24 B(+53.5%) | $12.65 B(+14.1%) |
June 2011 | - | $2.76 B(-3.1%) | $11.08 B(+0.2%) |
Mar 2011 | - | $2.85 B(+1.9%) | $11.06 B(+6.6%) |
Dec 2010 | $10.38 B(+23.4%) | $2.80 B(+4.6%) | $10.38 B(+5.8%) |
Sept 2010 | - | $2.67 B(-2.6%) | $9.80 B(+6.4%) |
June 2010 | - | $2.74 B(+26.9%) | $9.22 B(+8.5%) |
Mar 2010 | - | $2.16 B(-2.8%) | $8.50 B(+1.1%) |
Dec 2009 | $8.41 B(-0.4%) | $2.23 B(+6.7%) | $8.41 B(-0.9%) |
Sept 2009 | - | $2.09 B(+3.0%) | $8.48 B(+0.2%) |
June 2009 | - | $2.02 B(-2.3%) | $8.46 B(-0.3%) |
Mar 2009 | - | $2.07 B(-9.9%) | $8.49 B(+0.6%) |
Dec 2008 | $8.44 B(+13.9%) | $2.30 B(+11.1%) | $8.44 B(+5.2%) |
Sept 2008 | - | $2.07 B(+0.8%) | $8.02 B(+1.6%) |
June 2008 | - | $2.05 B(+1.7%) | $7.90 B(+3.3%) |
Mar 2008 | - | $2.02 B(+7.4%) | $7.64 B(+3.1%) |
Dec 2007 | $7.41 B(+16.7%) | $1.88 B(-3.4%) | $7.41 B(+2.4%) |
Sept 2007 | - | $1.95 B(+8.3%) | $7.23 B(+4.1%) |
June 2007 | - | $1.80 B(+0.5%) | $6.95 B(+4.1%) |
Mar 2007 | - | $1.79 B(+4.9%) | $6.67 B(+7.2%) |
Dec 2006 | $6.35 B | $1.70 B(+2.5%) | $6.22 B(+4.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2006 | - | $1.66 B(+9.3%) | $5.97 B(+4.4%) |
June 2006 | - | $1.52 B(+13.5%) | $5.72 B(+3.0%) |
Mar 2006 | - | $1.34 B(-7.4%) | $5.55 B(+0.9%) |
Dec 2005 | $5.50 B(+11.7%) | $1.45 B(+2.6%) | $5.50 B(+1.1%) |
Sept 2005 | - | $1.41 B(+4.3%) | $5.44 B(+5.1%) |
June 2005 | - | $1.35 B(+5.0%) | $5.17 B(+2.3%) |
Mar 2005 | - | $1.29 B(-7.2%) | $5.06 B(+2.7%) |
Dec 2004 | $4.92 B(+2.4%) | $1.39 B(+21.2%) | $4.92 B(+3.8%) |
Sept 2004 | - | $1.14 B(-7.5%) | $4.74 B(+2.5%) |
June 2004 | - | $1.24 B(+7.3%) | $4.63 B(-7.9%) |
Mar 2004 | - | $1.15 B(-4.7%) | $5.02 B(+3.2%) |
Dec 2003 | $4.81 B(+29.1%) | $1.21 B(+17.7%) | $4.86 B(+7.1%) |
Sept 2003 | - | $1.03 B(-37.0%) | $4.54 B(+1.4%) |
June 2003 | - | $1.63 B(+63.8%) | $4.48 B(+17.1%) |
Mar 2003 | - | $996.21 M(+12.2%) | $3.83 B(+2.8%) |
Dec 2002 | $3.72 B(-0.3%) | $887.94 M(-8.2%) | $3.72 B(-4.0%) |
Sept 2002 | - | $967.22 M(-1.1%) | $3.88 B(-0.7%) |
June 2002 | - | $978.01 M(+9.7%) | $3.91 B(+0.8%) |
Mar 2002 | - | $891.69 M(-14.6%) | $3.88 B(+3.9%) |
Dec 2001 | $3.73 B(+29.0%) | $1.04 B(+5.0%) | $3.73 B(+9.0%) |
Sept 2001 | - | $995.09 M(+4.9%) | $3.43 B(+9.5%) |
June 2001 | - | $948.20 M(+26.9%) | $3.13 B(+7.5%) |
Mar 2001 | - | $747.01 M(+1.5%) | $2.91 B(+0.6%) |
Dec 2000 | $2.89 B(+1.3%) | $735.65 M(+5.2%) | $2.89 B(-1.8%) |
Sept 2000 | - | $699.28 M(-4.1%) | $2.95 B(+0.3%) |
June 2000 | - | $728.94 M(-0.2%) | $2.94 B(+1.2%) |
Mar 2000 | - | $730.30 M(-7.3%) | $2.90 B(+1.6%) |
Dec 1999 | $2.86 B(+3.5%) | $788.13 M(+14.3%) | $2.86 B(+2.1%) |
Sept 1999 | - | $689.82 M(-0.6%) | $2.80 B(+0.9%) |
June 1999 | - | $693.70 M(+1.2%) | $2.77 B(+0.4%) |
Mar 1999 | - | $685.48 M(-6.1%) | $2.76 B(+0.1%) |
Dec 1998 | $2.76 B(+2.4%) | $730.30 M(+9.8%) | $2.76 B(+0.6%) |
Sept 1998 | - | $665.20 M(-2.5%) | $2.74 B(-0.4%) |
June 1998 | - | $682.16 M(-0.0%) | $2.75 B(+1.1%) |
Mar 1998 | - | $682.20 M(-4.3%) | $2.72 B(+0.9%) |
Dec 1997 | $2.70 B(+9.6%) | $713.10 M(+5.6%) | $2.70 B(+1.5%) |
Sept 1997 | - | $675.10 M(+3.7%) | $2.66 B(+2.3%) |
June 1997 | - | $651.00 M(-0.9%) | $2.60 B(+2.0%) |
Mar 1997 | - | $656.60 M(-2.5%) | $2.54 B(+3.4%) |
Dec 1996 | $2.46 B(+10.3%) | $673.12 M(+9.4%) | $2.46 B(+4.0%) |
Sept 1996 | - | $615.27 M(+2.7%) | $2.36 B(+4.1%) |
June 1996 | - | $598.90 M(+4.6%) | $2.27 B(+3.0%) |
Mar 1996 | - | $572.40 M(-0.9%) | $2.20 B(-1.2%) |
Dec 1995 | $2.23 B(+8.6%) | $577.88 M(+10.8%) | $2.23 B(+0.2%) |
Sept 1995 | - | $521.75 M(-2.0%) | $2.23 B(+0.3%) |
June 1995 | - | $532.28 M(-11.1%) | $2.22 B(+2.9%) |
Mar 1995 | - | $598.83 M(+4.5%) | $2.16 B(+4.9%) |
Dec 1994 | $2.05 B(+3.3%) | $572.96 M(+11.1%) | $2.05 B(+53.7%) |
Sept 1994 | - | $515.57 M(+10.0%) | $1.34 B(-12.0%) |
June 1994 | - | $468.74 M(-5.7%) | $1.52 B(-16.4%) |
Mar 1994 | - | $497.18 M(-444.3%) | $1.82 B(-8.5%) |
Dec 1993 | $1.99 B(-29.5%) | -$144.42 M(-120.7%) | $1.99 B(-30.4%) |
Sept 1993 | - | $698.10 M(-9.1%) | $2.86 B(+2.3%) |
June 1993 | - | $767.60 M(+15.1%) | $2.79 B(-2.7%) |
Mar 1993 | - | $666.90 M(-7.8%) | $2.87 B(+1.7%) |
Dec 1992 | $2.82 B(+29.4%) | $723.20 M(+14.3%) | $2.82 B(+4.9%) |
Sept 1992 | - | $632.90 M(-25.1%) | $2.69 B(+3.8%) |
June 1992 | - | $844.50 M(+36.2%) | $2.59 B(+13.5%) |
Mar 1992 | - | $620.00 M(+4.9%) | $2.28 B(+4.7%) |
Dec 1991 | $2.18 B(+18.3%) | $591.00 M(+10.7%) | $2.18 B(+4.4%) |
Sept 1991 | - | $534.10 M(-0.4%) | $2.09 B(+3.6%) |
June 1991 | - | $536.20 M(+3.5%) | $2.02 B(+4.1%) |
Mar 1991 | - | $518.30 M(+3.7%) | $1.94 B(+5.0%) |
Dec 1990 | $1.84 B(+15.0%) | $500.00 M(+8.5%) | $1.84 B(+37.2%) |
Sept 1990 | - | $460.90 M(+1.1%) | $1.34 B(+52.3%) |
June 1990 | - | $456.00 M(+7.1%) | $881.60 M(+107.1%) |
Mar 1990 | - | $425.60 M | $425.60 M |
Dec 1989 | $1.60 B(+8.1%) | - | - |
Dec 1988 | $1.48 B(+15.7%) | - | - |
Dec 1987 | $1.28 B(+20.7%) | - | - |
Dec 1986 | $1.06 B(+14.3%) | - | - |
Dec 1985 | $928.20 M(+7.7%) | - | - |
Dec 1984 | $862.10 M | - | - |
FAQ
- What is Abbott Laboratories annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Abbott Laboratories?
- What is Abbott Laboratories annual SG&A year-on-year change?
- What is Abbott Laboratories quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Abbott Laboratories?
- What is Abbott Laboratories quarterly SG&A year-on-year change?
- What is Abbott Laboratories TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Abbott Laboratories?
- What is Abbott Laboratories TTM SG&A year-on-year change?
What is Abbott Laboratories annual selling, general & administrative expenses?
The current annual SG&A of ABT is $10.95 B
What is the all time high annual SG&A for Abbott Laboratories?
Abbott Laboratories all-time high annual selling, general & administrative expenses is $11.32 B
What is Abbott Laboratories annual SG&A year-on-year change?
Over the past year, ABT annual selling, general & administrative expenses has changed by -$299.00 M (-2.66%)
What is Abbott Laboratories quarterly selling, general & administrative expenses?
The current quarterly SG&A of ABT is $2.90 B
What is the all time high quarterly SG&A for Abbott Laboratories?
Abbott Laboratories all-time high quarterly selling, general & administrative expenses is $4.24 B
What is Abbott Laboratories quarterly SG&A year-on-year change?
Over the past year, ABT quarterly selling, general & administrative expenses has changed by +$172.00 M (+6.32%)
What is Abbott Laboratories TTM selling, general & administrative expenses?
The current TTM SG&A of ABT is $152.97 B
What is the all time high TTM SG&A for Abbott Laboratories?
Abbott Laboratories all-time high TTM selling, general & administrative expenses is $12.65 B
What is Abbott Laboratories TTM SG&A year-on-year change?
Over the past year, ABT TTM selling, general & administrative expenses has changed by +$141.78 B (+1266.09%)